FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/031291 [Registered on: 15/02/2021] Trial Registered Prospectively
Last Modified On: 25/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study of Shadvidha Avekshya Kaala wsr to Madhyebhukta Aushadha Kaala 
Scientific Title of Study   Conceptual and Applied Study of Shadvidha Avekshya Kaala wsr to Madhyebhukta Aushadha Kaala 
Trial Acronym  SAK 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sunny Patil 
Designation  PhD (Ayu) scholar 
Affiliation  Institute of Teaching and Research in Ayurveda 
Address  Room no 305, Department of Basic Principles Institute of Teaching and Research in Ayurveda Jamnagar 361008
Room 305, Department of Basic Principles Institute of Teaching and Research in Ayurveda Jamnagar 361008
Jamnagar
GUJARAT
361008
India 
Phone    
Fax    
Email  sunnypatil125@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  AS Baghel 
Designation  Professor 
Affiliation  Institute of Teaching and Research in Ayurveda 
Address  Room no 310, Department of Basic Principles Institute of Teaching and Research in Ayurveda Jamnagar 361008
Room 310, Department of Basic Principles Institute of Teaching and Research in Ayurveda Jamnagar 361008
Jamnagar
GUJARAT
361008
India 
Phone    
Fax    
Email  asbaghel2001@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  AS Baghel 
Designation  Professor 
Affiliation  Institute of Teaching and Research in Ayurveda 
Address  Room No310, Department of Basic Principles Institute of Teaching and Research in Ayurveda Jamnagar 361008
Room 310, Department of Basic Principles Institute of Teaching and Research in Ayurveda Jamnagar 361008
Junagadh
GUJARAT
361008
India 
Phone    
Fax    
Email  asbaghel2001@yahoo.com  
 
Source of Monetary or Material Support  
Institute of Teaching and Research in Ayurveda Jamnagar 361008 
 
Primary Sponsor  
Name  Institute of Teaching and Research in Ayurveda  
Address  Institute of Teaching and Research in Ayurveda Jamnagar 361008  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sunny Patil  Institute of Teaching and Research in Ayurveda  OPD no 11, Department of Basic Principle, Institute of Teaching and Research in Ayurveda Jamnagar 361008
Jamnagar
GUJARAT 
9664366756

sunnypatil125@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute of Teaching and Research in Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K210||Gastro-esophageal reflux disease with esophagitis. Ayurveda Condition: VIDAGDHAJANYA-AJIRNAM/PITTAJA-AJIRNAM,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Abhayaadi Gutikaa  2 Gutikaa of 1gm each, twice a day Orallly at Madhyebhukta Kaala (in the middle of the meal, twice a day) with Jala for 14 Days  
Intervention  Abhayaadi Gutikaa  Abhayaadi Gutikaa 2 Gutikaa of 1gm each, twice a day Orally at Niranna Kaala (empty stomach, twice a day) with Jala for 14 Days  
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients in the age group between 18 to 60 years.
Patients having classical signs and symptoms of Vidagdhajirna (minimum 3 symptoms).
Patients having chronicity not more than one month.
 
 
ExclusionCriteria 
Details  Patients having age less than 18 years and more than 60 years.
Patients suffering from any systemic disease which intervenes with the treatment.
Patients having chronicity more than one month.
Patients in which one or more contents of Abhayaadi Gutikaa are contraindicated.
Pregnant and lactating women.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Establishment of role and importance of Shadvidha Avekshya Kaala in therapeutics in terms of better efficacy of the treatment prescribed.  4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To improve quality of life  28 days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "148"
Final Enrollment numbers achieved (India)="148" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   22/02/2021 
Date of Study Completion (India) 02/05/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 02/05/2022 
Estimated Duration of Trial   Years="1"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Indigestion-induced hyperacidity (Vidagdhajirna) treated with Ayurveda Shamana therapy: a single case study Journal of Indian System of Medicine ISSN No. P-2320-4419; E-2455-5029 Vol. 10, Issue. 4 December-2022 Page 265-270 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Introduction: In Ayurveda, more emphasis has been given to Kaala with regards to drug administration. According to Acharya Charaka, Kaala is the factor which determines the manifestation of desired effects of the administered drug therapy.

Significance: To fulfil the objectives like multidimensional usage and quick action of medicines and also to enhance the potency of Ayurveda treatment modality, administration of drugs with regards to Dina (different parts of the day), Atura (nature of the patient), Aushadha (nirannaadi aushadha kaala), Vyadhi (nature/stage of the disease), Jirna-linga (stage of the digestion of food) and Ritu (nature of the season) is of utmost importance.

Materials and Methods: The study will be carried out in two phases- Conceptual study and Clinical study. Clinical study will be started after obtaining clearance from Institutional Ethics Committee. Clinical study: Patients suffering from Vidagdhajirna will be divided into two groups by using computer generated randomization chart. Abhayaadi Gutikaa will be used as a drug and its efficacy given in two different Aushadha Kaalas will be evaluated.  

Group 1 will receive the drug at madhyebhukta kaala (in the middle of the meal, twice a day) while Group 2 will receive it at niranna kaala (empty stomach, twice a day).

Results and Discussion: Data generated during the above study will be presented in a systemic manner and shall be analyzed statistically.

Follow up: After completion of therapy, follow up will be done for 14 days to assess the status of patients. Adverse effects: This proposal will be reviewed and approved by Institutional Ethics Committee, I.T.R.A., Jamnagar which is having the responsibility to protect the research participants from harm. These drugs have no known unwanted effects. It is possible that it may also cause some problems that we are not aware of. Adverse Drug Reaction if any observed will be reported to the Pharmacovigilance cell of I.T.R.A., Jamnagar.

 
Close